Status:
NOT_YET_RECRUITING
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Lead Sponsor:
VA Office of Research and Development
Conditions:
Gout
Gouty Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 y...
Detailed Description
This project will quantify and compare the effects of a pharmacist-led telehealth-delivered intervention versus usual care on arthritis flare burden and serum urate goal achievement in 310 U.S. Vetera...
Eligibility Criteria
Inclusion
- US Veterans over the age of 18 years with physician-diagnosed
- Documented hyperuricemia (SU \>6.8 mg/dL)
- Satisfy ACR/EULAR gout classification criteria
- Report 1 or more flares in the prior 6 months
- Receipt of a new ULT prescription (allopurinol or febuxostat) initiated by a primary care provider or longer term ULT but otherwise satisfy the flare/SU criteria
Exclusion
- Any patient intolerant or unable to take ULTs (allopurinol or febuxostat)
- Patients with a rheumatology encounter within the prior 3 months
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2030
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT06887452
Start Date
March 1 2026
End Date
September 30 2030
Last Update
March 20 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska, United States, 68105-1850
2
VA Portland Health Care System, Portland, OR
Portland, Oregon, United States, 97207-2964
3
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, United States, 19104-4551
4
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah, United States, 84148-0001